NewEdge Advisors’s Applied Genetic Technologies Corporation AGTC Stock Holding History

NewEdge Advisors’s Portfolio AGTC Stock Details AGTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-14,000	Closed	-$4K	–	4275
2022 Q3	$4K	Buy	+14,000	New	+$6.11K	﹤0.01%	1519

NewEdge Advisors's AGTC Position: Q4 2022 in Review

NewEdge Advisors sold out of Applied Genetic Technologies Corporation (AGTC) in Q4 2022, closing a stake of 14,000 shares — an estimated $4K sold.

NewEdge Advisors first reported a position in AGTC in Q3 2022 and held it in 1 quarter. The position peaked at $4K in Q3 2022. 0 funds tracked by Wall St. Rank hold AGTC as of Q4 2022.

NewEdge Advisors reported no remaining Applied Genetic Technologies Corporation position as of Q4 2022 after selling out during the quarter.
NewEdge Advisors sold 14,000 Applied Genetic Technologies Corporation shares in Q4 2022, an estimated $4K.
NewEdge Advisors first reported a position in Applied Genetic Technologies Corporation in Q3 2022 and held it in 1 quarter.
NewEdge Advisors's Applied Genetic Technologies Corporation position peaked at $4K in Q3 2022.
0 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q4 2022.

Based on NewEdge Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.